Infinity enters alliance with Purdue and Mundipharma for early clinical and discovery programs Nov. 26, 2008
Oncolytics Biotech presents clinical results with its novel oncolytic reovirus type 3 Dearing Nov. 25, 2008
Synta initiates treatment of patients in phase I/II trial of elesclomol in prostate cancer Nov. 24, 2008
RSS